Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study
Adherence to disease-modifying therapies (DMTs) results in the reduction of the number and severity of relapses and delays the progression of multiple sclerosis (MS). Patients with lower adherence rates experi...